Differentieret implementering af HPV-baseret screening i dansk livmoderhalskræftscreening

Jesper Bonde; Jeppe Bennekou Schroll; Bettina Kjær Kristensen; Elsebeth Lynge; Maria Waldstrøm; Berit Andersen

Differentieret implementering af HPV-baseret screening i dansk livmoderhalskræftscreening

Jesper Bonde, Jeppe Bennekou Schroll, Bettina Kjær Kristensen, Elsebeth Lynge, Maria Waldstrøm, Berit Andersen

Abstract

Studies have shown, that HPV-based screening is more sensitive than cytology-based screening, but local factors will influence the performance. From January 2021 phased implementation of HPV-based screening was introduced in the Danish cervical cancer screening programme to women between 30 and 59 years. Women with even birth dates will remain on the current cytology-based screening, whereas women with odd birth dates will receive HPV-based screening. The aim of the implementation is to provide guidance to the National Health Authority on the future Danish cervical screening, as argued in this review.

Bidragets oversatte titel	Phased implementation of HPV-based cervical cancer screening in Denmark
Originalsprog	Dansk
Artikelnummer	V04210327
Tidsskrift	Ugeskrift for Laeger
Vol/bind	184
Udgave nummer	9
Sider (fra-til)	1-8
Antal sider	8
ISSN	0041-5782
Status	Udgivet - 28 feb. 2022

Emneord

Cervical Intraepithelial Neoplasia
Denmark/epidemiology
Early Detection of Cancer
Female
Humans
Mass Screening
Papillomaviridae
Papillomavirus Infections/diagnosis
Uterine Cervical Neoplasms/diagnosis
Vaginal Smears

Adgang til dokumentet

https://ugeskriftet.dk/files/scientific_article_files/2022-02/v04210327_web.pdf

Citationsformater

@article{2fa485562f7e4479808c276900d6d82b,

title = "Differentieret implementering af HPV-baseret screening i dansk livmoderhalskr{\ae}ftscreening",

abstract = "Studies have shown, that HPV-based screening is more sensitive than cytology-based screening, but local factors will influence the performance. From January 2021 phased implementation of HPV-based screening was introduced in the Danish cervical cancer screening programme to women between 30 and 59 years. Women with even birth dates will remain on the current cytology-based screening, whereas women with odd birth dates will receive HPV-based screening. The aim of the implementation is to provide guidance to the National Health Authority on the future Danish cervical screening, as argued in this review.",

keywords = "Cervical Intraepithelial Neoplasia, Denmark/epidemiology, Early Detection of Cancer, Female, Humans, Mass Screening, Papillomaviridae, Papillomavirus Infections/diagnosis, Uterine Cervical Neoplasms/diagnosis, Vaginal Smears",

author = "Jesper Bonde and Schroll, {Jeppe Bennekou} and Kristensen, {Bettina Kj{\ae}r} and Elsebeth Lynge and Maria Waldstr{\o}m and Berit Andersen",

year = "2022",

month = feb,

day = "28",

language = "Dansk",

volume = "184",

pages = "1--8",

journal = "Ugeskrift for Laeger",

issn = "0041-5782",

publisher = "Almindelige Danske Laegeforening",

number = "9",

}

TY - JOUR

T1 - Differentieret implementering af HPV-baseret screening i dansk livmoderhalskræftscreening

AU - Bonde, Jesper

AU - Schroll, Jeppe Bennekou

AU - Kristensen, Bettina Kjær

AU - Lynge, Elsebeth

AU - Waldstrøm, Maria

AU - Andersen, Berit

PY - 2022/2/28

Y1 - 2022/2/28

N2 - Studies have shown, that HPV-based screening is more sensitive than cytology-based screening, but local factors will influence the performance. From January 2021 phased implementation of HPV-based screening was introduced in the Danish cervical cancer screening programme to women between 30 and 59 years. Women with even birth dates will remain on the current cytology-based screening, whereas women with odd birth dates will receive HPV-based screening. The aim of the implementation is to provide guidance to the National Health Authority on the future Danish cervical screening, as argued in this review.

AB - Studies have shown, that HPV-based screening is more sensitive than cytology-based screening, but local factors will influence the performance. From January 2021 phased implementation of HPV-based screening was introduced in the Danish cervical cancer screening programme to women between 30 and 59 years. Women with even birth dates will remain on the current cytology-based screening, whereas women with odd birth dates will receive HPV-based screening. The aim of the implementation is to provide guidance to the National Health Authority on the future Danish cervical screening, as argued in this review.

KW - Cervical Intraepithelial Neoplasia

KW - Denmark/epidemiology

KW - Early Detection of Cancer

KW - Female

KW - Humans

KW - Mass Screening

KW - Papillomaviridae

KW - Papillomavirus Infections/diagnosis

KW - Uterine Cervical Neoplasms/diagnosis

KW - Vaginal Smears

M3 - Review

C2 - 35244023

SN - 0041-5782

VL - 184

SP - 1

EP - 8

JO - Ugeskrift for Laeger

JF - Ugeskrift for Laeger

IS - 9

M1 - V04210327

ER -

Differentieret implementering af HPV-baseret screening i dansk livmoderhalskræftscreening

Abstract

Emneord

Adgang til dokumentet

Fingeraftryk

Citationsformater